Catalent | Company Profile - Revenue, Headcount, Tech Stack, Contacts

Catalent is a global leader in contract development and manufacturing, specializing in drug development, delivery, and supply for pharmaceuticals, biologics, consumer health, and self-care products. Established in 2007, it has a rich history rooted in innovations such as the softgel encapsulation process. The company has grown extensively through strategic acquisitions, including Aptuit, Micron Technologies, and Cook Pharmica, and operates more than 50 sites worldwide.

Catalent offers comprehensive CDMO solutions focused on advanced drug delivery technologies and reliable manufacturing processes. Services span oral dose forms, biologics development, and clinical supply chain management. Key technologies include softgels, Zydis Ultra, and specialized platforms for molecular optimization. Catalent has supported numerous FDA approvals and product launches, serving a broad portfolio of clients in the pharmaceutical and biotech sectors.